OLANZAPINE TEVA ® 7.5 MG

Country: Ísrael

Tungumál: enska

Heimild: Ministry of Health

Virkt innihaldsefni:

OLANZAPINE 7.5 MG

Fáanlegur frá:

SALOMON,LEVIN & ELSTEIN LTD

ATC númer:

N05AH03

Lyfjaform:

FILM COATED TABLETS

Stjórnsýsluleið:

PER OS

Framleitt af:

TEVA OPERATIONS POLAND SP.ZO.O

Meðferðarhópur:

OLANZAPINE

Ábendingar:

Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Leyfisdagur:

2011-04-01